Publications by authors named "Masaya Koshizaka"

Background And Aims: Early prevention of chronic kidney disease is critical. We aimed to identify predictive risk factors for early-stage renal dysfunction.

Methods And Results: This retrospective study analyzed specific health checkup data from the general Japanese population.

View Article and Find Full Text PDF

Purpose: Epidemiological studies have reported that environmental factors from fetal period to early childhood can influence the risk of non-communicable diseases in adulthood. This concept has been termed the developmental origins of health and disease (DOHaD). The Chiba study of Mother and Child Health (C-MACH) is a DOHaD concept-based birth cohort study which started in 2014.

View Article and Find Full Text PDF

Background And Aim: Werner syndrome (WS) is an autosomal recessive, adult-onset, progeroid syndrome caused by mutations. As refractory skin ulcers significantly affect the quality of life of patients with WS, this study identified ulcer risk factors and assessed prevention methods.

Methods: We analyzed the data of 51 patients with WS enrolled in the Japanese Werner Syndrome Registry between 2016 and 2022.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic retinopathy (DR) is a common eye complication in type 2 diabetes, significantly affecting patients' vision and quality of life.
  • This study analyzed data from patients in Japan to compare the risk of DR in those treated with sodium-glucose cotransporter-2 inhibitors (SGLT2i) versus dipeptidyl peptidase-4 inhibitors (DPP-4i).
  • Results showed that patients on SGLT2i had a lower incidence of DR diagnoses compared to those on DPP-4i, indicating SGLT2i may help prevent DR in early-stage type 2 diabetes.
View Article and Find Full Text PDF

The patient was a 54-year-old woman with familial hypercholesterolemia and remarkable Achilles tendon thickening. At 20 years old, the patient had a total cholesterol level of approximately 300 mg/dL. She started receiving rosuvastatin (5 mg/day) for low-density lipoprotein cholesterol (LDL-C) 235 mg/dL at 42 years old, which was increased to 10 mg/day at 54 years old, decreasing her serum LDL-C level to approximately 90 mg/dL.

View Article and Find Full Text PDF

Aims/introduction: Severe diabetic macular edema (DME) is often resistant to anti-vascular endothelial growth factor therapy. Steroids are particularly effective at reducing edema by suppressing inflammation; they are also used as an alternative to expensive anti-vascular endothelial growth factor therapy in some patients. Therefore, the use of steroids in DME reflects an unmet need for anti-vascular endothelial growth factor therapy.

View Article and Find Full Text PDF

Aim: We assessed the effectiveness of sodium-glucose co-transporter 2 inhibitors (SGLT2is) in reducing the administration frequency of anti-vascular endothelial growth factor (VEGF) agents in patients with diabetic macular oedema (DMO) using a health insurance claims database.

Materials And Methods: This retrospective cohort study analysed health insurance claims data covering 11 million Japanese patients between 2005 and 2019. We analysed the frequency and duration of intravitreal injection of anti-VEGF agents after initiating SGLT2is or other antidiabetic drugs.

View Article and Find Full Text PDF

Aim: Whether sex differences exist in hereditary progeroid syndromes remains unclear. In this study, we investigated sex differences in patients with Werner syndrome (WS), a model of human aging, using patient data at the time of diagnosis.

Methods: The presence of six cardinal signs in the diagnostic criteria was retrospectively evaluated.

View Article and Find Full Text PDF

Werner syndrome (WS) is a hereditary premature aging disorder characterized by visceral fat accumulation and subcutaneous lipoatrophy, resulting in severe insulin resistance. However, its underlying mechanism remains unclear. In this study, we show that senescence-associated inflammation and suppressed adipogenesis play a role in subcutaneous adipose tissue reduction and dysfunction in WS.

View Article and Find Full Text PDF

Study Objective: The effects of the sodium-dependent glucose transporter-2 inhibitor ipragliflozin were compared with metformin in a previous study, which revealed that ipragliflozin reduced visceral fat content by 12%; however, the underlying mechanism was unclear. Therefore, this sub-analysis aimed to compare metabolomic changes associated with ipragliflozin and metformin that may contribute to their biological effects.

Design: A sub-analysis of a randomized controlled study.

View Article and Find Full Text PDF

Mitochondrial dysfunction causes maternally inherited deafness and diabetes (MIDD). Herein, we report improved glycemic control in a 47-year-old Japanese woman with MIDD using imeglimin without major adverse effects. Biochemical tests and metabolome analysis were performed before and after imeglimin administration.

View Article and Find Full Text PDF

Psoriasis is a chronic inflammatory skin disease that is associated with obesity and myocardial infarction. Obesity-induced changes in lipid metabolism promote T helper 17 (Th17) cell differentiation, which in turn promotes chronic inflammation. Th17 cells have central roles in many inflammatory diseases, including psoriasis and atherosclerosis; however, whether treatment of obesity attenuates Th17 cells and chronic inflammatory diseases has been unknown.

View Article and Find Full Text PDF
Article Synopsis
  • Werner syndrome is an adult-onset progeria syndrome that shows a high prevalence of malignant tumors, particularly starting in the fifth decade of life, affecting about 30% of patients in a studied group of 51 individuals over three years.
  • The study involved annual data collection through the Werner Syndrome Registry, which revealed significant declines in renal function, with the average estimated glomerular filtration rate (eGFR) dropping from 74.8 to 63.4 mL/min over four years.
  • Findings highlight the need for thorough monitoring and careful management of medications due to the rapid health deterioration associated with gonadal tumors and renal function decline in patients with Werner syndrome.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the presence and significance of antibodies against the PCSK9 protein in patients with diabetes, focusing on their potential role as a prognostic marker for mortality.
  • Results show that levels of PCSK9 antibodies (PCSK9-Abs) are significantly higher in diabetes patients compared to healthy donors, but these antibodies do not correlate with PCSK9 protein levels.
  • Higher levels of PCSK9-Abs are associated with increased mortality in diabetes patients, suggesting they could serve as a new marker for predicting overall mortality, warranting further research.
View Article and Find Full Text PDF

Design: Retrospective cohort study. . The data was obtained from a total of 87 PA patients treated with esaxerenone.

View Article and Find Full Text PDF

Aim: The aims of this study were to assess the general quality of life and foot/ankle health-related quality of life among subjects with Werner syndrome (WS) and to determine subjective foot/ankle symptoms associated with quality of life.

Methods: Using a questionnaire survey, patients were asked to provide information on age, sex and presence of subjective symptoms and complete both the 36-Item Short Form Health Survey (SF-36) questionnaire and the Self-Administered Foot Evaluation Questionnaire (SAFE-Q). Statistical analyses were performed using Student's t-test, the Mann-Whitney U test, Fisher's exact test and Spearman's rank correlation.

View Article and Find Full Text PDF

Background: Werner syndrome is a rare, autosomal recessive disorder characterised by premature aging. It is a typical hereditary progeroid syndrome that can be difficult to diagnose owing to its rarity and the similarity of some of its symptoms, such as juvenile cataracts, to other common ophthalmologic conditions. Early onset of bilateral cataracts is currently used as the ophthalmological feature for Werner syndrome; however, ophthalmologists often find performing a detailed examination of the medical history and genetic testing for Werner syndrome at the time of an ophthalmologic consultation challenging.

View Article and Find Full Text PDF

Aim: To identify predictive factors for surgical site infection (SSI) in patients with type 2 diabetes and develop a prediction tool.

Materials And Methods: We retrospectively analyzed the perioperative blood glucose management of 105 patients with type 2 diabetes treated from 2016 to 2018 at Chiba University Hospital. The primary outcome was SSI onset within 30 postoperative days; moreover, predictive factors were identified using univariate analysis.

View Article and Find Full Text PDF

The prevalence of familial lipoprotein lipase deficiency (LPLD) is approximately one in 1,000,000 in the general population. There are conflicting reports on whether or not LPLD is atherogenic. We conducted coronary computed tomographic (CT) angiography on two patients in their 70 s who had genetically confirmed LPLD.

View Article and Find Full Text PDF

Background: Werner syndrome (WS) is an autosomal recessive premature ageing disease that causes accelerated ageing-like symptoms after puberty. Previous studies conducted in the late 2000s reported that malignant neoplasms and atherosclerotic diseases were the two leading causes of death, with life expectancies in the mid-50 s. However, the recent lifespan and cause of death in patients with WS remain unclear.

View Article and Find Full Text PDF

Purpose: To determine the efficacy of systemic sodium-glucose co-transporter 2 inhibitors (SGLT2i) on diabetic macular edema (DME).

Methods: The medical records of patients with DME with a central retinal thickness (CRT) ≥320 µm in men and 305 µm in women, more than 6 months after the initiation of diabetes mellitus treatment, were reviewed. The CRT and best-corrected visual acuity (BCVA) were evaluated before and after the initiation of systemic SGLT2i and non-SGLT2i treatments.

View Article and Find Full Text PDF